symbol,synonyms,gene_locus,gene_id,transcript_id,conservation,conservation_ortholog,conservation_species,biological_context,context_detail,tissue/cell line,genome_variation,variation_detail,epigenetic_modification,modification_detail,expression,expression_detail,regulator_type,regulator,regulator_interaction,regulator_effect,target_type,target,target_interaction,target_effect,experimental_method,molecular_function,biological_process,pathway,functional_mechanism,clinical_detail,drug,description,pmid
ADARB2-AS1,bA466B20.1;C10orf109;NCRNA00168,10p15.3,HSALNG0075559,"HSALNT0157365,HSALNT0157367,HSALNT0157368,HSALNT0157369,HSALNT0157370,HSALNT0157371,HSALNT0157372,HSALNT0289522,HSALNT0355598,HSALNT0355599,HSALNT0355600,HSALNT0355601,HSALNT0355602,HSALNT0355603,HSALNT0355604",,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg17672798,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30712078
BACE1-AS,FJ573250;NCRNA00177;BACE1-AS1;BACE1AS,11q23.3,HSALNG0087449,"HSALNT0181744,HSALNT0181745,HSALNT0181747,HSALNT0181748,HSALNT0181749,HSALNT0288891,HSALNT0365090,HSALNT0365091",,NA,,Disease,alzheimer's disease,Brain tissue,NA,NA,NA,NA,RNA,Up-regulated,NA,NA,NA,NA,NA,NA,NA,NA,Bioinformatic analysis;Array,NA,NA,NA,Post-transcriptional regulation,NA,NA,"We identify a conserved noncoding antisense transcript forb-secretase-1 (bace1),a crucial enzyme in alzheimer's disease pathophysiology.The bace1-antisense transcript (bace1-as) regulates bace1 mrna and subsequently bace1 protein expressionin vitro andin vivo.Upon exposure to various cell stressors including amyloid-b1-42(ab1-42),expression of bace1-as becomes elevated,increasing bace1 mrna stability and generating additional ab1-42 through a post-transcriptional feed-forward mechanism.Bace1-as concentrations were elevated in subjects with alzheimer's disease and in amyloid precursor protein transgenic mice.The bace1-antisense transcript (bace1-as) regulates bace1 mrna and subsequently bace1 protein expression in vitro and in vivo.Bace1 mrna expression is under the control of a regulatory noncoding rna that may drive alzheimer's disease-associated pathophysiology.Elevated levels of ab,bace1 proteins,as well as bace1-as have been detected in subjects with alzheimer's disease (ad),suggesting that altered bace1 expression plays a role in the pathogenesis of the disease.Bace1-as is directly implicated in the increased abundance of a就鈠in alzheimer's disease.Here we report that bace1-as,a natural antisense transcript,plays a part in determining bace1 expression.Bace1-as rapidly and reversibly upregulates bace1 levels in response to a variety of stresses,including a就鈠exposure.Furthermore,weshow elevated bace1-as in several brain regions of individuals with alzheimer's disease.These data suggest that this previously unexamined noncoding rna has a role in regulating bace1 and in driving alzheimer's disease pathology.Bace1-as and bace1 transcripts were measured by rt-pcr and normalized to actb as an endogenous control.",18587408
BACE1-AS,FJ573250;NCRNA00177;BACE1-AS1;BACE1AS,11q23.3,HSALNG0087449,"HSALNT0181744,HSALNT0181745,HSALNT0181747,HSALNT0181748,HSALNT0181749,HSALNT0288891,HSALNT0365090,HSALNT0365091",,NA,,Disease,alzheimer's disease,Neuronal cell,NA,NA,NA,NA,RNA,Up-regulated,NA,NA,NA,NA,miRNA,miR-148a,NA,Promote,Array,NA,NA,NA,NA,NA,NA,"In addition,neuronal cells exposed to diverse cell stressors (e.G.,reactive oxygen species,chronic hypoxia,and a就鈩 exhibited increased expression and nuclear to cytoplasmic translocation of bace1-as transcripts,where bace1-as promotes the stabilization of bace1 mrna and up-regulation of bace1 protein.",20380817
BACE1-AS,FJ573250;NCRNA00177;BACE1-AS1;BACE1AS,11q23.3,HSALNG0087449,"HSALNT0181744,HSALNT0181745,HSALNT0181747,HSALNT0181748,HSALNT0181749,HSALNT0288891,HSALNT0365090,HSALNT0365091",,NA,,Disease,alzheimer's disease,NA,NA,NA,NA,NA,RNA,Down-regulated,NA,NA,NA,NA,NA,NA,NA,NA,Array,NA,NA,NA,ceRNA,NA,NA,"We report here that bace1-antisense prevents mirna-induced repression of bace1 mrna by masking the binding site for mir-485-5p.Indeed,mir-485-5p and bace1-antisense compete for binding within the same region in the open reading frame of the bace1 mrnawe found that the expression of bace1-antisense as well as mir-485-5p are dysregulated in rna samples from alzheimer's disease subjects compared to control individuals.",20507594
BACE1-AS,FJ573250;NCRNA00177;BACE1-AS1;BACE1AS,11q23.3,HSALNG0087449,"HSALNT0181744,HSALNT0181745,HSALNT0181747,HSALNT0181748,HSALNT0181749,HSALNT0288891,HSALNT0365090,HSALNT0365091",,NA,,Disease,alzheimer's disease,NA,NA,NA,NA,NA,RNA,Differentially expressed,NA,NA,NA,NA,NA,NA,NA,NA,Bioinformatic analysis,NA,NA,NA,NA,NA,NA,The bace1-antisense transcript (bace1-as) is markedly upregulated in brain samples from ad patients and promotes the stability of the (sense) bace1 transcript.,21785702
BACE1-AS,FJ573250;NCRNA00177;BACE1-AS1;BACE1AS,11q23.3,HSALNG0087449,"HSALNT0181744,HSALNT0181745,HSALNT0181747,HSALNT0181748,HSALNT0181749,HSALNT0288891,HSALNT0365090,HSALNT0365091",,NA,,Disease,alzheimer's disease,NA,NA,NA,NA,NA,RNA,Differentially expressed,NA,NA,NA,NA,NA,NA,NA,NA,Bioinformatic analysis,NA,NA,NA,NA,NA,NA,"It has been shown that misexpression of lncRNAs contributes to numerous diseases.For example,an lncRNA may influence the pathogenesis of alzheimer's disease.The bace1-as can regulate bace1 mrna expression.Bace1 mrna expression is under the control of a regulatory non-coding rna that may drive alzheimer's disease-associated pathophysiology.",22535282
BACE1-AS,FJ573250;NCRNA00177;BACE1-AS1;BACE1AS,11q23.3,HSALNG0087449,"HSALNT0181744,HSALNT0181745,HSALNT0181747,HSALNT0181748,HSALNT0181749,HSALNT0288891,HSALNT0365090,HSALNT0365091",,NA,,Disease,alzheimer's disease,NA,NA,NA,NA,NA,RNA,Differentially expressed,NA,NA,NA,NA,NA,NA,NA,NA,Bioinformatic analysis,NA,NA,NA,NA,NA,NA,"Bace1 is one of two peptidases that carry out the initial proteolytic cleavage of app,allowing it to accumulate in the brain.Bace1as levels were found to be higher in human subjects with ad,and also in bace1 transgenic mouse models of ad.",22817756
BACE1-AS,FJ573250;NCRNA00177;BACE1-AS1;BACE1AS,11q23.3,HSALNG0087449,"HSALNT0181744,HSALNT0181745,HSALNT0181747,HSALNT0181748,HSALNT0181749,HSALNT0288891,HSALNT0365090,HSALNT0365091",,NA,,Disease,alzheimer's disease,NA,NA,NA,NA,NA,RNA,Differentially expressed,NA,NA,NA,NA,NA,NA,NA,NA,Bioinformatic analysis,NA,NA,NA,NA,NA,NA,He accumulation of this protein has been implicated in many neurological disorders and elevated levels of both bace1 and bace1-as have been detected in subjects with alzheimer's disease.,22928560
BACE1-AS,FJ573250;NCRNA00177;BACE1-AS1;BACE1AS,11q23.3,HSALNG0087449,"HSALNT0181744,HSALNT0181745,HSALNT0181747,HSALNT0181748,HSALNT0181749,HSALNT0288891,HSALNT0365090,HSALNT0365091",,NA,,Disease,alzheimer's disease,NA,NA,NA,NA,NA,RNA,Differentially expressed,NA,NA,NA,NA,NA,NA,NA,NA,Bioinformatic analysis,NA,NA,NA,NA,NA,NA,"Bace1-as is elevated in brains of patients with ad,suggesting that the lncRNA is the driving force behind bace1 dysregulation in ad.",23562612
BACE1-AS,FJ573250;NCRNA00177;BACE1-AS1;BACE1AS,11q23.3,HSALNG0087449,"HSALNT0181744,HSALNT0181745,HSALNT0181747,HSALNT0181748,HSALNT0181749,HSALNT0288891,HSALNT0365090,HSALNT0365091",,NA,,Disease,alzheimer's disease,NA,NA,NA,NA,NA,RNA,Differentially expressed,NA,NA,NA,NA,NA,NA,NA,NA,Bioinformatic analysis,NA,NA,NA,NA,NA,NA,Genomic context links lncRNAs to disease genes/loci and related pathways.,23791884
BACE1-AS,FJ573250;NCRNA00177;BACE1-AS1;BACE1AS,11q23.3,HSALNG0087449,"HSALNT0181744,HSALNT0181745,HSALNT0181747,HSALNT0181748,HSALNT0181749,HSALNT0288891,HSALNT0365090,HSALNT0365091",,NA,,Disease,alzheimer's disease,NA,NA,NA,NA,NA,RNA,Differentially expressed,NA,NA,NA,NA,NA,NA,NA,NA,Bioinformatic analysis,NA,NA,NA,NA,NA,NA,The expression of bace1 antisense transcript (bace1-as) was linked to increased amyloid-就鈠in patients with alzheimer锛妔 disease and gave rise for a stabilizing function of the lncRNA.,24531795
BACE1-AS,FJ573250;NCRNA00177;BACE1-AS1;BACE1AS,11q23.3,HSALNG0087449,"HSALNT0181744,HSALNT0181745,HSALNT0181747,HSALNT0181748,HSALNT0181749,HSALNT0288891,HSALNT0365090,HSALNT0365091",,NA,,Disease,alzheimer's disease,NA,NA,NA,NA,NA,RNA,Differentially expressed,NA,NA,NA,NA,NA,NA,NA,NA,Bioinformatic analysis,NA,NA,NA,NA,NA,NA,"In alzheimer disease,the protein-coding gene bace-1 (βsite amyloid precursor protein-cleaving enzyme) cleaves amyloid precursor protein (app) to βamyloid peptide (a尬the accumulation of which (amyloid plaques) is associated with disease.LncRNA bace1-as,located on the antisense strand to bace1,binds complementarily to bace1 mrna,increases its stability,regulates bace1 translation,and thereby the production of a對",24667321
BACE1-AS,FJ573250;NCRNA00177;BACE1-AS1;BACE1AS,11q23.3,HSALNG0087449,"HSALNT0181744,HSALNT0181745,HSALNT0181747,HSALNT0181748,HSALNT0181749,HSALNT0288891,HSALNT0365090,HSALNT0365091",,NA,,Disease,alzheimer's disease,Brain tissue,NA,NA,NA,NA,RNA,Up-regulated,NA,NA,NA,NA,NA,NA,NA,NA,Array,NA,NA,NA,NA,NA,NA,"Hud also associated with and stabilized the long noncoding (lnc)rna bace1as,which partly complements bace1 mrna and enhances bace1 expression.Consistent with hud promoting production of app and app-cleaving enzyme,the levels of app,bace1,bace1as,and abeta were higher in the brain of hud-overexpressing mice.Importantly,cortex (superior temporal gyrus) from patients with ad displayed significantly higher levels of hud and,accordingly,elevated app,bace1,bace1as,and abeta than did cortical tissue from healthy age-matched individuals.",24857657
BACE1-AS,FJ573250;NCRNA00177;BACE1-AS1;BACE1AS,11q23.3,HSALNG0087449,"HSALNT0181744,HSALNT0181745,HSALNT0181747,HSALNT0181748,HSALNT0181749,HSALNT0288891,HSALNT0365090,HSALNT0365091",,NA,,Disease,alzheimer's disease,NA,NA,NA,NA,NA,RNA,Up-regulated,NA,NA,NA,NA,miRNA,miR-129-5p,RNA-RNA,NA,Array,NA,NA,NA,NA,NA,NA,"The senile plaque (sp) ad shsy5y cell model was established using the synthetic amyloid betaprotein (abeta) 142 in vitro.Quantitative polymerase chain reaction and western blot analysis revealed that the mrna and protein expression of abeta142 and abeta140 was significantly increased in the ad model group,with a marked decrease in ki67 expression at day six.Rnase protection assays (rpa) and northern blotting analysis confirmed that exogenous abeta142 not only promoted the expression of the app cleaving enzyme bace1,but also induced lncRNA bace1as expression.Furthermore,lncRNA bace1as formed rna duplexes and increased the stability of bace1 mrnadownregulation of lncRNA bace1as expression in shsy5y cells by sirna silencing resulted in the attenuation of the ability of bace1 to cleave app and delayed the induction of sp formation in the sp ad shsy5y cell model.",24970022
BACE1-AS,FJ573250;NCRNA00177;BACE1-AS1;BACE1AS,11q23.3,HSALNG0087449,"HSALNT0181744,HSALNT0181745,HSALNT0181747,HSALNT0181748,HSALNT0181749,HSALNT0288891,HSALNT0365090,HSALNT0365091",,NA,,Disease,alzheimer's disease,NA,NA,NA,NA,NA,RNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Array,NA,NA,NA,NA,NA,NA,Bace1-as levels are up-regulated in ad brains where bace1-as acts by stabilizing bace1 mrna thereby increasing bace1 protein content and a尠formation.,27338628
BCYRN1,BC200;BC200a;NCRNA00004;LINC00004,2p21,ENSG00000236824.2,,Y,NA,Anthropoidea,Disease,alzheimer's disease,Brain tissue,NA,NA,NA,NA,RNA,Up-regulated,NA,NA,NA,NA,NA,NA,NA,NA,Array,NA,NA,NA,NA,NA,NA,"Bc200 rna was significantly up-regulated in ad brains,in comparison with age-matched normal brains.",17553964
BCYRN1,BC200;BC200a;NCRNA00004;LINC00004,2p21,ENSG00000236824.2,,Y,NA,Anthropoidea,Disease,alzheimer's disease,Brain tissue,NA,NA,NA,NA,RNA,Up-regulated,NA,NA,NA,NA,miRNA,miR-129-5p,RNA-RNA,NA,Array,NA,NA,NA,NA,NA,NA,"Another study utilized human ad brain tissue to link alterations in levels of a lncRNA,bc200,with ad pathogenesis (mus et al.,2007).Increased levels of bc200 were found in brain regions that are preferentially affected in ad,such as brodmann's area 9 and the hippocampus,which correlated with disease severity measured by clinical dementia rating scores.",20380817
BCYRN1,BC200;BC200a;NCRNA00004;LINC00004,2p21,ENSG00000236824.2,,Y,NA,Anthropoidea,Disease,alzheimer's disease,Neural stem cell,NA,NA,NA,NA,RNA,Up-regulated,NA,NA,NA,NA,NA,NA,NA,NA,Array,NA,NA,NA,NA,NA,NA,"A study has shown that bc200 rna is upregulated in the frontal cortex of the ad brains compared to the age-matched controls.The expression level of bc200 rna is increased in parallel with the ad progression.In human nervous system,bc200 rna is expressed by a subpopulation of neurons analogous to bc1 rna,a 152 nt noncoding rna localized in the dendrite-rich neuropil areas.",21969146
BCYRN1,BC200;BC200a;NCRNA00004;LINC00004,2p21,ENSG00000236824.2,,Y,NA,Anthropoidea,Disease,alzheimer's disease,NA,NA,NA,NA,NA,RNA,Differentially expressed,NA,NA,NA,NA,NA,NA,NA,NA,Meta-analysis,NA,NA,NA,NA,NA,NA,"Bc200 levels in brodmann's area 9 (the area of brain affected in ad) were found to be higher in age-matched ad brains compared with normal brains,and the relative levels of bc200 rna in affected areas increased with the severity of ad.",23562612
BCYRN1,BC200;BC200a;NCRNA00004;LINC00004,2p21,ENSG00000236824.2,,Y,NA,Anthropoidea,Disease,alzheimer's disease,NA,NA,NA,NA,NA,RNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Array,NA,NA,NA,NA,NA,NA,Overexpression of bc200 rna leads to inadequate rna delivery to the synapses and results in neurodegenerative processes of alzheimer's disease and neoplastic changes in various groups of tissues.,26596549
CALHM6-AS1,RP1-93H18.6,6q22.1,HSALNG0053007,"HSALNT0112198,HSALNT0112199,HSALNT0112200,HSALNT0112201",,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg14419141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30712078
CARMN,CARMEN;MIR143HG,5q32,HSALNG0045753,"HSALNT0096060,HSALNT0096061,HSALNT0096062,HSALNT0096064,HSALNT0096065,HSALNT0096069,HSALNT0096070,HSALNT0096071,HSALNT0096075,HSALNT0096076,HSALNT0288904,HSALNT0330170,HSALNT0330171,HSALNT0330172,HSALNT0330173,HSALNT0330174,HSALNT0330175,HSALNT0330176,HSALNT0330177,HSALNT0330178,HSALNT0330179,HSALNT0330180,HSALNT0330181,HSALNT0330182,HSALNT0330183,HSALNT0330184,HSALNT0330185,HSALNT0330186,HSALNT0330187,HSALNT0330188,HSALNT0330189,HSALNT0330190,HSALNT0330191,HSALNT0330192,HSALNT0330193,HSALNT0330194,HSALNT0330195,HSALNT0330196,HSALNT0330197,HSALNT0330198,HSALNT0330199,HSALNT0330200,HSALNT0330201",,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg22941668,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,25129075
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,alzheimer's disease,NA,SNP,rs11515,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Genotyping,NA,NA,NA,NA,NA,NA,"Recent studies showed that single nucleotide polymorphisms (rs3217992,a>g,rs1063192,c>t) mapping in the vicinity of anril are linked to a wide spectrum of conditions,including cardiovascular disease,ischemic stroke,type 2 diabetes,frailty and alzheimer's disease.",18761660
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,alzheimer's disease,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Genotyping,NA,NA,NA,NA,NA,NA,Genetic variation in lncRNA genes causes disease and influences susceptibility.,23791884
CYP1B1-AS1,MGC34824;C2orf58,2p22.2,HSALNG0014289,"HSALNT0030190,HSALNT0030191,HSALNT0030192,HSALNT0030195,HSALNT0030196,HSALNT0030198,HSALNT0030199,HSALNT0030201,HSALNT0030207,HSALNT0030208,HSALNT0030209,HSALNT0030210,HSALNT0030211,HSALNT0030213,HSALNT0030215,HSALNT0030216,HSALNT0030218,HSALNT0030220,HSALNT0030222,HSALNT0030224,HSALNT0030225,HSALNT0030227,HSALNT0030229,HSALNT0030231,HSALNT0030233,HSALNT0030235,HSALNT0030237,HSALNT0030239,HSALNT0030241,HSALNT0030242,HSALNT0030245,HSALNT0030246,HSALNT0030249,HSALNT0030250,HSALNT0030251,HSALNT0030253,HSALNT0030255,HSALNT0030257,HSALNT0030259,HSALNT0030261,HSALNT0030262,HSALNT0030279,HSALNT0030284,HSALNT0301780,HSALNT0301781,HSALNT0301782,HSALNT0301783,HSALNT0301784,HSALNT0301785,HSALNT0301786,HSALNT0301787,HSALNT0301788,HSALNT0301789,HSALNT0301790,HSALNT0301791,HSALNT0301794,HSALNT0301795,HSALNT0301796,HSALNT0301802,HSALNT0301803,HSALNT0301813",,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg27368726,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30045751
DIP2C-AS1,FLJ38681;C10orf108;PRR26,10p15.3,,,,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg16942135;cg23681599,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30712078
DIP2C-AS1,FLJ38681;C10orf108;PRR26,10p15.3,,,,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg19683608,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30830696
DLEU1,LEU1;XTP6;NCRNA00021;LINC00021;BCMS1;DLB1;BCMS,13q14.2-q14.3,,,,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg20733077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,25129075
DLEU2,LEU2;TRIM13OS;NCRNA00022;LINC00022;MIR15AHG;DLB2;BCMSUN;RFP2OS,13q14.2,HSALNG0097094,"HSALNT0201676,HSALNT0201677,HSALNT0201680,HSALNT0201681,HSALNT0201683,HSALNT0201687,HSALNT0201690,HSALNT0201691,HSALNT0201694,HSALNT0201697,HSALNT0201701,HSALNT0201703,HSALNT0201704,HSALNT0201705,HSALNT0201707,HSALNT0201708,HSALNT0201710,HSALNT0201712,HSALNT0201714,HSALNT0201715,HSALNT0201719,HSALNT0201720,HSALNT0201724,HSALNT0201727,HSALNT0201728,HSALNT0201729,HSALNT0201731,HSALNT0201733,HSALNT0201736,HSALNT0201738,HSALNT0201742,HSALNT0201744,HSALNT0373348,HSALNT0373349,HSALNT0373350,HSALNT0373351,HSALNT0373352,HSALNT0373353,HSALNT0373354,HSALNT0373355,HSALNT0373356,HSALNT0373357,HSALNT0373358,HSALNT0373359,HSALNT0373360,HSALNT0373361,HSALNT0373362,HSALNT0373363,HSALNT0373364,HSALNT0373365,HSALNT0373366,HSALNT0373367,HSALNT0373368,HSALNT0373369,HSALNT0373370",,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg20733077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,25129075
DRAIC,,15q23,,,,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg16125725,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30712078
HAR1A,HAR1F;NCRNA00064;LINC00064,20q13.33,HSALNG0131591,"HSALNT0270426,HSALNT0270427,HSALNT0270430,HSALNT0270431,HSALNT0289475,HSALNT0402446,HSALNT0402447,HSALNT0402448,HSALNT0402449,HSALNT0402450",,NA,,Disease,alzheimer's disease,NA,NA,NA,NA,NA,RNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Immunoblot,NA,NA,NA,NA,NA,NA,Schizophrenia spectrum disorders and ad have also been linked with the rheelin (reln) gene and its antisense transcript har1.,22817756
HAR1B,HAR1R;NCRNA00065;LINC00065,20q13.33,HSALNG0131589,"HSALNT0270416,HSALNT0270417,HSALNT0270418,HSALNT0270419,HSALNT0270420,HSALNT0270421,HSALNT0270423,HSALNT0270424,HSALNT0288995,HSALNT0402439,HSALNT0402440,HSALNT0402441,HSALNT0402442,HSALNT0402443,HSALNT0402444,HSALNT0402445",,NA,,Disease,alzheimer's disease,NA,NA,NA,NA,NA,RNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Immunoblot,NA,NA,NA,NA,NA,NA,Schizophrenia spectrum disorders and ad have also been linked with the rheelin (reln) gene and its antisense transcript har1.,22817756
HOXA-AS2,HOXA3as,7p15.2,HSALNG0056854,"HSALNT0120328,HSALNT0120329,HSALNT0120330,HSALNT0120332,HSALNT0120334,HSALNT0120335,HSALNT0120337,HSALNT0120338,HSALNT0120340,HSALNT0120343,HSALNT0120344,HSALNT0120345,HSALNT0120347,HSALNT0120350,HSALNT0120351,HSALNT0339890,HSALNT0339891,HSALNT0339892,HSALNT0339893,HSALNT0339894,HSALNT0339895,HSALNT0339896,HSALNT0339897,HSALNT0339898,HSALNT0339899,HSALNT0339900,HSALNT0339901,HSALNT0339902,HSALNT0339903,HSALNT0339904,HSALNT0339905,HSALNT0339906,HSALNT0339907,HSALNT0339908,HSALNT0339909,HSALNT0339910,HSALNT0339911,HSALNT0339915",,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg22962123,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,25129075
HOXA-AS2,HOXA3as,7p15.2,HSALNG0056854,"HSALNT0120328,HSALNT0120329,HSALNT0120330,HSALNT0120332,HSALNT0120334,HSALNT0120335,HSALNT0120337,HSALNT0120338,HSALNT0120340,HSALNT0120343,HSALNT0120344,HSALNT0120345,HSALNT0120347,HSALNT0120350,HSALNT0120351,HSALNT0339890,HSALNT0339891,HSALNT0339892,HSALNT0339893,HSALNT0339894,HSALNT0339895,HSALNT0339896,HSALNT0339897,HSALNT0339898,HSALNT0339899,HSALNT0339900,HSALNT0339901,HSALNT0339902,HSALNT0339903,HSALNT0339904,HSALNT0339905,HSALNT0339906,HSALNT0339907,HSALNT0339908,HSALNT0339909,HSALNT0339910,HSALNT0339911,HSALNT0339915",,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg07061298;cg13172549,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30045751
KCNQ1OT1,KvDMR1;KCNQ1-AS2;KvLQT1-AS;LIT1;NCRNA00012,11p15.5,HSALNG0082235,"HSALNT0171216,HSALNT0171217,HSALNT0171219,HSALNT0289421,HSALNT0361046,HSALNT0361047,HSALNT0361048,HSALNT0361049,HSALNT0361050,HSALNT0361058",,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg02219360;cg20699737,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30712078
KIAA1614-AS1,RP11-46A10.4,1q25.3,HSALNG0008840,"HSALNT0018289,HSALNT0296852",,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg13467459,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30830696
LINC01080,TCONS_00021856,13q31.1,,,,NA,,Disease,alzheimer's disease,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Genotyping,NA,NA,NA,NA,NA,NA,"Single-nucleotide polymorphisms (snps) of long intergenic noncoding rna (lincrna) at the genome level indicated that a genetic variant,rs7990916,in the lincrna 01080 (linc01080) may play an important role in the physiology and pathophysiology of the human brain.",25019275
LINC01616,n341006,11p14.1,HSALNG0083371,"HSALNT0173548,HSALNT0289348",,NA,,Disease,alzheimer's disease,Brain tissue,NA,NA,NA,NA,RNA,Down-regulated,NA,NA,NA,NA,NA,NA,NA,NA,Microarray,NA,NA,NA,NA,NA,NA,"LncRNA n341006 is associated with protein ubiquitination pathway/among the most downregulated lncRNAs,We found an intergenic lncRNA n341006 (genbank: ak095844) significantly associated with genes involved in protein ubiquitination pathway.",26318290
LINC01772,ENSG00000226029,1p36.13,HSALNG0141680,"HSALNT0290450,HSALNT0290451",,NA,,Disease,alzheimer's disease,Alzheimer's disease tissue,NA,NA,NA,NA,RNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Microarray;Q-RCR,NA,NA,NA,NA,NA,NA,"Prioritization of lncRNAs from a microarray (gse53622) of oesophageal cancer patients highlighted ensg00000226029 (top 2),a previously unidentified lncRNA as a potential prognostic biomarker.",27992375
LINC02580,AC093609.1,2p21,HSALNG0014517,"HSALNT0030814,HSALNT0030815,HSALNT0030816,HSALNT0030818,HSALNT0030824,HSALNT0030826,HSALNT0030827,HSALNT0030829,HSALNT0030833,HSALNT0030843,HSALNT0030844,HSALNT0030845,HSALNT0030846,HSALNT0030848,HSALNT0302056,HSALNT0302058,HSALNT0302080,HSALNT0302081,HSALNT0302082,HSALNT0302083,HSALNT0302084,HSALNT0302085,HSALNT0302086,HSALNT0302087,HSALNT0302088,HSALNT0302089,HSALNT0302090,HSALNT0302091,HSALNT0302092,HSALNT0302093,HSALNT0302094,HSALNT0302095,HSALNT0302096,HSALNT0302097,HSALNT0302098,HSALNT0302099,HSALNT0302100,HSALNT0302101,HSALNT0302102,HSALNT0302103,HSALNT0302104,HSALNT0302117,HSALNT0302118,HSALNT0302119",,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg03125400,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30045751
LRP1-AS,,12q13.3,HSALNG0091595,"HSALNT0189951,HSALNT0189952,HSALNT0189954,HSALNT0368537,HSALNT0368538,HSALNT0368539,HSALNT0368540",,NA,,Disease,alzheimer's disease,Brain tissue,NA,NA,NA,NA,RNA,Up-regulated,NA,NA,NA,NA,NA,NA,NA,NA,QRT-PCR;Luciferase reporter gene assay;Wetern blotting assay,NA,NA,NA,NA,NA,NA,"Here we identify a nat of low-density lipoprotein receptor-related protein 1 (lrp1),referred to as lrp1-as,that negatively regulates lrp1 expression.We show that lrp1-as directly binds to high mobility group box 2 (hmgb2) and inhibits the activity of hmgb2 to enhance srebp1a-dependent transcription of lrp1.",25937287
LRRC2-AS1,LUZP3;LUZPP1;LUZP3P,3p21.3,HSALNG0025700,"HSALNT0054010,HSALNT0054011,HSALNT0054012,HSALNT0054013,HSALNT0054014,HSALNT0054015,HSALNT0054016,HSALNT0311657,HSALNT0311658",,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg24524379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30712078
MIAT,FLJ25967;Rncr2;gomafu;NCRNA00066;LINC00066;lncRNA-MIAT;C22orf35,22q12.1,,,,NA,,Disease,alzheimer's disease,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Bioinformatic analysis,NA,NA,NA,NA,NA,NA,"We show that miat knockdown leads to cerebral microvascular degeneration,progressive neuronal loss and neurodegeneration,and  behavioral deficits in a cns neurovascular disorder,alzheimer's disease.",27391072
MIR100HG,AGD1;lncRNA-N2;linc-NeD125,11q24.1,HSALNG0087764,"HSALNT0182356,HSALNT0182357,HSALNT0182358,HSALNT0182359,HSALNT0182360,HSALNT0182361,HSALNT0182362,HSALNT0182363,HSALNT0182370,HSALNT0182371,HSALNT0182372,HSALNT0182373,HSALNT0182374,HSALNT0182375,HSALNT0182377,HSALNT0182378,HSALNT0182379,HSALNT0182381,HSALNT0182383,HSALNT0182385,HSALNT0182387,HSALNT0182388,HSALNT0182389,HSALNT0182391,HSALNT0182393,HSALNT0182395,HSALNT0182399,HSALNT0182402,HSALNT0182403,HSALNT0182405,HSALNT0182407,HSALNT0182409,HSALNT0182414,HSALNT0182415,HSALNT0182416,HSALNT0182418,HSALNT0182421,HSALNT0182422,HSALNT0182426,HSALNT0182427,HSALNT0182428,HSALNT0182429,HSALNT0182431,HSALNT0182432,HSALNT0182434,HSALNT0182437,HSALNT0182438,HSALNT0182441,HSALNT0182442,HSALNT0182447,HSALNT0182449,HSALNT0182451,HSALNT0182452,HSALNT0182455,HSALNT0182457,HSALNT0182459,HSALNT0182461,HSALNT0182462,HSALNT0182464,HSALNT0182465,HSALNT0182467,HSALNT0182469,HSALNT0182482,HSALNT0182484,HSALNT0182499,HSALNT0182501,HSALNT0182503,HSALNT0182505,HSALNT0182506,HSALNT0182508,HSALNT0182510,HSALNT0182512,HSALNT0182514,HSALNT0182517,HSALNT0182518,HSALNT0182523,HSALNT0182531,HSALNT0182532,HSALNT0182534,HSALNT0182548,HSALNT0182549,HSALNT0289173,HSALNT0365357,HSALNT0365358,HSALNT0365359,HSALNT0365360,HSALNT0365361,HSALNT0365362,HSALNT0365363,HSALNT0365364,HSALNT0365365,HSALNT0365366,HSALNT0365367,HSALNT0365368,HSALNT0365369,HSALNT0365370,HSALNT0365371,HSALNT0365372,HSALNT0365373,HSALNT0365374,HSALNT0365375,HSALNT0365376,HSALNT0365377,HSALNT0365378,HSALNT0365379,HSALNT0365380,HSALNT0365381,HSALNT0365382,HSALNT0365383,HSALNT0365384,HSALNT0365385,HSALNT0365386,HSALNT0365387,HSALNT0365388,HSALNT0365389,HSALNT0365390,HSALNT0365391,HSALNT0365392,HSALNT0365393,HSALNT0365394,HSALNT0365395,HSALNT0365396,HSALNT0365397,HSALNT0365398,HSALNT0365399,HSALNT0365400,HSALNT0365401,HSALNT0365402,HSALNT0365403,HSALNT0365404,HSALNT0365405,HSALNT0365406,HSALNT0365407,HSALNT0365408,HSALNT0365409,HSALNT0365410,HSALNT0365411,HSALNT0365412,HSALNT0365413,HSALNT0365414,HSALNT0365415,HSALNT0365416,HSALNT0365417,HSALNT0365418,HSALNT0365419,HSALNT0365420,HSALNT0365421,HSALNT0365422,HSALNT0365423,HSALNT0365424,HSALNT0365425,HSALNT0365426,HSALNT0365427,HSALNT0365428,HSALNT0365429,HSALNT0365430,HSALNT0365431,HSALNT0365432,HSALNT0365433,HSALNT0365434,HSALNT0365435,HSALNT0365436,HSALNT0365437,HSALNT0365438,HSALNT0365439,HSALNT0365440,HSALNT0365441,HSALNT0365442,HSALNT0365443,HSALNT0365444,HSALNT0365445,HSALNT0365446,HSALNT0365447,HSALNT0365448,HSALNT0365449,HSALNT0365450,HSALNT0365451,HSALNT0365452,HSALNT0365453,HSALNT0365454,HSALNT0365455,HSALNT0365456,HSALNT0365457,HSALNT0365458",,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg24864707,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30830696
NEAT1,TncRNA;MENepsilon/beta;LINC00084;VINC;NCRNA00084,11q13.1,HSALNG0084892,"HSALNT0176751,HSALNT0176753,HSALNT0176757,HSALNT0176758,HSALNT0176759,HSALNT0176762,HSALNT0176765,HSALNT0289192,HSALNT0363258,HSALNT0363259,HSALNT0363260,HSALNT0363261,HSALNT0363262,HSALNT0363263,HSALNT0363264,HSALNT0363265,HSALNT0363266,HSALNT0363267,HSALNT0363268,HSALNT0363269,HSALNT0363270,HSALNT0363271,HSALNT0363272,HSALNT0363273,HSALNT0363274,HSALNT0363275,HSALNT0363276,HSALNT0363277,HSALNT0363278,HSALNT0363279,HSALNT0363280,HSALNT0363281,HSALNT0363282,HSALNT0363283,HSALNT0363284,HSALNT0363285,HSALNT0363286,HSALNT0363287,HSALNT0363289",Y,NA,Placental mammal,Disease,alzheimer's disease,NA,NA,NA,NA,NA,RNA,Down-regulated,NA,NA,NA,NA,PCG,CDK5R1,NA,Inhibit,RNAi;Q-RCR,NA,NA,NA,NA,NA,NA,"Multiple layers of cdk5r1 regulation in alzheimer's disease implicate long non-coding rnas.We demonstrated that neat1 and hotair negatively regulate cdk5r1 mrna levels,while malat1 has a positive effect.Weobserved a strong positive correlation between cdk5r1 and neat1 expression levels in brain tissues,suggesting a possible neuroprotective role of neat1 in ad to compensate for increased cdk5r1 levels.Overall,our work provides evidence of another level of cdk5r1 expression regulation mediated by lncRNAs and points to neat1 as a biomarker,as well as a potential pharmacological target for ad therapy.",29997370
PCAT7,PCAN-R2,9q22.32,HSALNG0072923,"HSALNT0152401,HSALNT0152402,HSALNT0152403,HSALNT0152404,HSALNT0152405,HSALNT0152406,HSALNT0152407,HSALNT0152408,HSALNT0152409,HSALNT0152410,HSALNT0152411,HSALNT0152412,HSALNT0152413,HSALNT0152414,HSALNT0152415,HSALNT0152416,HSALNT0152418,HSALNT0152419,HSALNT0152421,HSALNT0152422,HSALNT0152423,HSALNT0152424,HSALNT0152425,HSALNT0152426,HSALNT0152427,HSALNT0152428,HSALNT0152429,HSALNT0152431,HSALNT0289210,HSALNT0353775,HSALNT0353776,HSALNT0353777,HSALNT0353778,HSALNT0353779,HSALNT0353780,HSALNT0353781,HSALNT0353782,HSALNT0353783,HSALNT0353784,HSALNT0353785,HSALNT0353786,HSALNT0353787",,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg20356482,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30712078
PVT1,NCRNA00079;LINC00079;onco-lncRNA-100;MIR1204HG,8q24.21,HSALNG0068477,"HSALNT0143703,HSALNT0143704,HSALNT0143705,HSALNT0143718,HSALNT0143719,HSALNT0143720,HSALNT0143723,HSALNT0143732,HSALNT0143737,HSALNT0143738,HSALNT0143739,HSALNT0143740,HSALNT0143741,HSALNT0143742,HSALNT0143743,HSALNT0143746,HSALNT0143748,HSALNT0143749,HSALNT0143756,HSALNT0143757,HSALNT0143758,HSALNT0143759,HSALNT0143760,HSALNT0143761,HSALNT0143762,HSALNT0143763,HSALNT0143764,HSALNT0143765,HSALNT0143766,HSALNT0143772,HSALNT0143773,HSALNT0143778,HSALNT0143782,HSALNT0143783,HSALNT0289225,HSALNT0349930,HSALNT0349931,HSALNT0349932,HSALNT0349933,HSALNT0349934,HSALNT0349935,HSALNT0349936,HSALNT0349937,HSALNT0349938,HSALNT0349939,HSALNT0349940,HSALNT0349941,HSALNT0349942,HSALNT0349943,HSALNT0349944,HSALNT0349945,HSALNT0349946,HSALNT0349947,HSALNT0349948,HSALNT0349949,HSALNT0349950,HSALNT0349951,HSALNT0349952,HSALNT0349953,HSALNT0349954,HSALNT0349955,HSALNT0349956,HSALNT0349957,HSALNT0349958,HSALNT0349959,HSALNT0349960,HSALNT0349961,HSALNT0349962,HSALNT0349963,HSALNT0349964,HSALNT0349965,HSALNT0349966,HSALNT0349967,HSALNT0349968,HSALNT0349969,HSALNT0349970,HSALNT0349971,HSALNT0349972,HSALNT0349973,HSALNT0349974,HSALNT0349975,HSALNT0349976,HSALNT0349977,HSALNT0349978,HSALNT0349979,HSALNT0349980,HSALNT0349981,HSALNT0349982,HSALNT0349983,HSALNT0349984,HSALNT0349985,HSALNT0349986,HSALNT0349987,HSALNT0349988,HSALNT0349989,HSALNT0349990,HSALNT0349991,HSALNT0349992,HSALNT0349993,HSALNT0349994,HSALNT0349995,HSALNT0349996,HSALNT0349997,HSALNT0349998,HSALNT0349999,HSALNT0350000,HSALNT0350001,HSALNT0350002,HSALNT0350003,HSALNT0350004,HSALNT0350005,HSALNT0350006,HSALNT0350007,HSALNT0350008,HSALNT0350009,HSALNT0350010,HSALNT0350011,HSALNT0350012,HSALNT0350013,HSALNT0350014,HSALNT0350015,HSALNT0350016,HSALNT0350017,HSALNT0350018,HSALNT0350019,HSALNT0350020,HSALNT0350021,HSALNT0350022,HSALNT0350023,HSALNT0350024,HSALNT0350025,HSALNT0350026,HSALNT0350027,HSALNT0350028,HSALNT0350029,HSALNT0350030,HSALNT0350031,HSALNT0350032,HSALNT0350033,HSALNT0350034,HSALNT0350035,HSALNT0350036,HSALNT0350037,HSALNT0350038,HSALNT0350039,HSALNT0350040,HSALNT0350041,HSALNT0350042,HSALNT0350043,HSALNT0350044,HSALNT0350045,HSALNT0350046,HSALNT0350047,HSALNT0350048,HSALNT0350049,HSALNT0350050,HSALNT0350051,HSALNT0350052,HSALNT0350053,HSALNT0350054,HSALNT0350055,HSALNT0350056,HSALNT0350057,HSALNT0350058,HSALNT0350059,HSALNT0350060,HSALNT0350061,HSALNT0350062,HSALNT0350063,HSALNT0350064,HSALNT0350065,HSALNT0350066,HSALNT0350067,HSALNT0350068,HSALNT0350069,HSALNT0350070,HSALNT0350071,HSALNT0350072,HSALNT0350073,HSALNT0350074,HSALNT0350075,HSALNT0350076,HSALNT0350077,HSALNT0350078,HSALNT0350079,HSALNT0350080,HSALNT0350081,HSALNT0350082,HSALNT0350083,HSALNT0350084,HSALNT0350085,HSALNT0350086,HSALNT0350087,HSALNT0350088,HSALNT0350089,HSALNT0350090,HSALNT0350091,HSALNT0350092,HSALNT0350093,HSALNT0350094,HSALNT0350095,HSALNT0350096,HSALNT0350097,HSALNT0350098,HSALNT0350099,HSALNT0350100,HSALNT0350101,HSALNT0350102,HSALNT0350103,HSALNT0350104,HSALNT0350105,HSALNT0350106,HSALNT0350107,HSALNT0350108,HSALNT0350109,HSALNT0350110,HSALNT0350111,HSALNT0350112,HSALNT0350113,HSALNT0350114,HSALNT0350115,HSALNT0350116,HSALNT0350118,HSALNT0350122,HSALNT0350123",,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg19508622,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30712078
SNHG14,NCRNA00214;UBE3A-AS;UBE3A-ATS;UBE3A-AS1,15q11.2,,,,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg08343671;cg13994177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30712078
TUG1,FLJ20618;NCRNA00080;LINC00080,22q12.2,HSALNG0134930,"HSALNT0276950,HSALNT0276953,HSALNT0276954,HSALNT0289417,HSALNT0405694,HSALNT0405695,HSALNT0405696,HSALNT0405697,HSALNT0405698,HSALNT0405699,HSALNT0405700,HSALNT0405701,HSALNT0405702,HSALNT0405703,HSALNT0405704,HSALNT0405705,HSALNT0405706,HSALNT0405707,HSALNT0405708,HSALNT0405709,HSALNT0405710,HSALNT0405711,HSALNT0405712,HSALNT0405713,HSALNT0405714,HSALNT0405715,HSALNT0405716,HSALNT0405717,HSALNT0405718",TRUE,N/A,Human;Mouse;Rat;Cow;Dog,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg12449837,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30712078
UMODL1-AS1,FLJ33471;C21orf128,21q22.3,HSALNG0133282,HSALNT0274011,,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg19766460;cg24372256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30712078
ZEB1-AS1,,10p11.22,HSALNG0077083,"HSALNT0160881,HSALNT0160885,HSALNT0160887,HSALNT0160892,HSALNT0160893,HSALNT0160894,HSALNT0160896,HSALNT0160898,HSALNT0160899,HSALNT0160901,HSALNT0160903,HSALNT0160904,HSALNT0160906,HSALNT0160907,HSALNT0160908,HSALNT0160910,HSALNT0160911,HSALNT0160912,HSALNT0160913,HSALNT0289285,HSALNT0357173,HSALNT0357174,HSALNT0357175,HSALNT0357176,HSALNT0357177,HSALNT0357178,HSALNT0357179,HSALNT0357180,HSALNT0357181,HSALNT0357182,HSALNT0357183,HSALNT0357184,HSALNT0357185,HSALNT0357186,HSALNT0357187,HSALNT0357188,HSALNT0357189,HSALNT0357190,HSALNT0357191,HSALNT0357192,HSALNT0357193,HSALNT0357194,HSALNT0357195,HSALNT0357196,HSALNT0357197,HSALNT0357198,HSALNT0357199,HSALNT0357200,HSALNT0357201,HSALNT0357202",,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg07089783,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30045751
ZNF295-AS1,PRED87;C21orf121;NCRNA00318,21q22.3,HSALNG0133273,"HSALNT0273990,HSALNT0273992,HSALNT0273993,HSALNT0273995,HSALNT0273999,HSALNT0274000,HSALNT0274001,HSALNT0274006,HSALNT0289291,HSALNT0404347,HSALNT0404348,HSALNT0404349,HSALNT0404350,HSALNT0404351,HSALNT0404352,HSALNT0404353,HSALNT0404354,HSALNT0404355,HSALNT0404356,HSALNT0404357,HSALNT0404358,HSALNT0404359,HSALNT0404360,HSALNT0404361",,NA,,Disease,alzheimer's disease,NA,NA,NA,DNA methylation,cg18559568,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30712078
RMRP,,,HSALNG0142285,HSALNT0290170,,NA,,Disease,Alzheimers disease,Brain,NA,NA,NA,NA,RNA,Up-regulated,NA,NA,NA,NA,miRNA,miR-3142,RNA-RNA,Inhibit,"QRT-PCR,Luciferase reporter assay",NA,Apoptosis,NA,ceRNA,NA,NA,,35304105
